The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Gamida Cell Ltd(NASDAQ:GMDA) 
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that is in Phase III studies in patients with high-risk hematologic malignancies, as well as in P...
Website: http://www.gamida-cell.com
Founded: 1998
Full Time Employees: 79
Sector: Healthcare
Industry: Biotechnology
Gamida Cell Days Payable Outstanding ttm (DPO)
Gamida Cell Days Receivable Outstanding ttm (DSO)
Gamida Cell Days Inventory Outstanding ttm (DIO)
Gamida Cell Op Cashflow Per Share ttm
Gamida Cell Free Cashflow Per Share ttm
Gamida Cell Cash Per Share ttm
Gamida Cell P/S ratio ttm
Gamida Cell (GAAP) P/E ratio ttm
Gamida Cell P/B ratio ttm
No extra charts and metrics for this ticker.